NCT02906397
Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) treatment 1 completed NCT02814461
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC treatment 1 completed NCT06309485
Phase 2 Study of WGI-0301 for Advanced HCC treatment 2 not_yet_recruiting NCT04212221
MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients treatment 1 / 2 terminated NCT04523493
Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC treatment 3 active_not_recruiting NCT01101906
A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC treatment 2 terminated NCT04985136
A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT04605796
A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT04344158
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) treatment 3 not_yet_recruiting NCT04723004
Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC treatment 3 active_not_recruiting NCT05375604
A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC) No drug interventions treatment 1 terminated NCT02509169
Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT05862181
The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT06600321
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma treatment 1 recruiting NCT06644430
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT04514484
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV treatment 1 active_not_recruiting NCT06618664
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma treatment 3 not_yet_recruiting NCT06624098
Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05092373
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax treatment 1 recruiting NCT05883644
Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) treatment 3 recruiting NCT06427941
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab, in Participants With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT04740307
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004) treatment 2 active_not_recruiting NCT06609863
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT06595108
ATezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT06550921
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05213221
Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients treatment 2 completed NCT04072679
Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma treatment 1 completed NCT01214343
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC treatment 3 unknown_status NCT05028933
IMC001 for Clinical Research on Advanced Digestive System Malignancies No drug interventions treatment 1 recruiting NCT04101747
To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic Effect No drug interventions Not Available Not Available unknown_status NCT05975645
A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). treatment 1 recruiting NCT04973098
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT05173298
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Not Available Not Available recruiting NCT05773105
A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC treatment 1 / 2 active_not_recruiting NCT05797805
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT05924997
Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT05592197
Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT treatment Not Available withdrawn NCT01429961
Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT01356628
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer treatment 2 active_not_recruiting NCT00667628
Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 terminated NCT01192971
A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT04730388
ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or No drug interventions Not Available Not Available unknown_status NCT05070156
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma No drug interventions treatment 0 active_not_recruiting NCT05718232
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH) treatment 3 not_yet_recruiting NCT04052152
Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT06418659
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients No drug interventions treatment 0 not_yet_recruiting NCT05352542
GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma No drug interventions treatment 1 terminated NCT03605706
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. treatment 3 unknown_status NCT04862949
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC Not Available Not Available completed NCT04401813
Efficacy and Safety of IBI310 Combined With Sintilimab in Patients With Advanced Hepatocellular Carcinoma treatment 1 active_not_recruiting NCT01539018
Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE treatment 2 terminated NCT05317819
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma treatment 3 recruiting NCT00752063
Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma treatment 2 unknown_status NCT04828486
Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer treatment 2 recruiting NCT04756648
Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma No drug interventions treatment 1 recruiting NCT05791448
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease No drug interventions treatment 1 recruiting NCT02638857
Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma treatment 1 / 2 unknown_status NCT06370065
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients treatment 2 recruiting NCT01656265
Study of ARQ 197 in Hepatocellular Carcinoma (HCC) treatment 1 completed NCT04611165
Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC treatment 2 unknown_status NCT00241020
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma treatment 3 completed NCT00756782
A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 withdrawn NCT00999882
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients treatment 1 completed NCT03586973
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma treatment 2 completed NCT06233994
A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular Carcinoma treatment Not Available not_yet_recruiting NCT04709380
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT treatment 3 recruiting NCT06320080
Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma. treatment 1 not_yet_recruiting NCT03905967
TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC treatment 3 unknown_status NCT00882869
XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT00872014
A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer treatment 2 completed NCT05176223
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer treatment 2 recruiting NCT04777708
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer treatment 0 terminated NCT02528643
A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma treatment 2 completed NCT03993743
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT00534664
Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma No drug interventions treatment 1 / 2 completed NCT04417764
TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma. No drug interventions treatment 1 recruiting NCT06326502
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma No drug interventions treatment 1 recruiting NCT05845502
Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT04503902
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT03059147
Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma treatment 1 terminated NCT05057845
Cryoablation Combined With Tislelizumab Plus Lenvatinib as Second-line or Later Therapy in Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT05628545
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells No drug interventions treatment 1 / 2 withdrawn NCT00731445
Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) No drug interventions treatment 1 / 2 completed NCT04294498
Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection treatment 2 active_not_recruiting NCT04948697
A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC treatment 2 completed NCT01942083
A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma) treatment 1 terminated NCT05097911
Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma. treatment 1 recruiting NCT05444088
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04183088
Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT03980288
4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3 No drug interventions treatment 1 completed NCT06470256
Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma treatment 1 recruiting NCT04358185
Itacitinib in Advanced Hepatocellular Carcinoma treatment 1 active_not_recruiting NCT06374485
Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment No drug interventions treatment 1 recruiting NCT04000737
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT04430452
Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Cancer After Progression on PD-1 Inhibition treatment 2 recruiting NCT01129570
Siliphos in Advanced Hepatocellular Carcinoma treatment 1 completed NCT05783570
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307 No drug interventions treatment 1 recruiting NCT06301399
Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study treatment 2 not_yet_recruiting NCT05620706
Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT02632006
Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma No drug interventions treatment 1 / 2 unknown_status NCT02150317
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT06461624
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma No drug interventions treatment 1 not_yet_recruiting NCT05738616
Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study) treatment 3 recruiting NCT01964235
Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma treatment 2 withdrawn NCT06363825
A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT05117957
Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study treatment 2 enrolling_by_invitation NCT05981066
A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05290220
HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT00517920
Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) treatment 2 completed NCT06323382
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma Not Available Not Available recruiting NCT04066660
Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC) No drug interventions supportive_care Not Available suspended NCT02834780
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma treatment 1 completed NCT02795429
Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC treatment 1 / 2 completed NCT01033240
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer treatment 2 completed NCT02724267
Targeted Internal Radiation Therapy in Advanced HCC Patients. No drug interventions treatment Not Available completed NCT03841201
Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma treatment 2 completed NCT05620004
Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy treatment 1 / 2 recruiting NCT04487704
Camrelizumab Utilization on Patients With Advanced Liver Cancer No drug interventions treatment Not Available recruiting NCT06244446
Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma. No drug interventions Not Available Not Available not_yet_recruiting NCT00495846
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma treatment 2 / 3 completed NCT06092112
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 0 not_yet_recruiting NCT01897610
Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC No drug interventions treatment 2 completed NCT04442581
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer treatment 2 terminated NCT02227914
Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma treatment 1 / 2 withdrawn NCT04331743
A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC treatment 1 unknown_status